Valbiotis first — half 2026 net loss narrows to EUR 3.37 million; revenue more than doubles to EUR 765,000
Valbiotis posted H1 2026 net sales of EUR 765,000, up 130% year over year. Operating result narrowed to a loss of EUR 3.16 million, while net result improved to a loss of EUR 3.37 million. Operating expenses rose 8% to EUR 5.5 million, with sales and marketing costs up 16% to EUR 2.98 million. Cash and cash equivalents